358 filings
Page 2 of 18
8-K
2r5kavdp
12 Sep 23
Departure of Directors or Certain Officers
4:31pm
S-8
e8px361d07 2fwsp
8 Aug 23
Registration of securities for employees
5:21pm
S-3ASR
atn5i8o6 pz
24 Jul 23
Automatic shelf registration
4:06pm
8-K
dk6 lfa8p
17 Jul 23
Regulation FD Disclosure
7:06am
8-K
xqhvb5ic39z30
10 Jul 23
Regulation FD Disclosure
5:13pm
8-K
wwjpgrazyneymjf
16 Jun 23
Departure of Directors or Certain Officers
4:31pm
8-K
dtq1lht3v y8
9 May 23
Viridian Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:10pm
ARS
xuyvqxvibwhe ws2pxf
28 Apr 23
Annual report to shareholders
8:28am
DEFA14A
yxdjy2
28 Apr 23
Additional proxy soliciting materials
8:27am
8-K
86knf47 h1kjge
12 Apr 23
Departure of Directors or Certain Officers
8:06am
S-8
j6clkem 9wrutqr
10 Mar 23
Registration of securities for employees
5:07pm
8-K
j7i58r7h
10 Mar 23
Regulation FD Disclosure
3:22pm
8-K
o41ttmt75xs3lw5
8 Mar 23
Viridian Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides
7:06am
8-K
xpud1et31er2gja epo
6 Feb 23
Viridian Appoints Scott Myers as President and Chief Executive Officer
7:06am
8-K
psh o48nws
9 Jan 23
Regulation FD Disclosure
6:06am